Form N-PX GUGGENHEIM STRATEGIC For: Jun 30
Tweet
Share
E-mailSerious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Pyxis Oncology closes public offering with $110M in upfront proceeds
- Guggenheim Reiterates Buy Rating on Walt Disney (DIS)
- Pyxis Oncology prices public offering for ~$110M in gross proceeds
Create E-mail Alert Related Categories
SEC FilingsRelated Entities
GuggenheimSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
